Eplerenone Completed Phase 3 Trials for Duchenne's Muscular Dystrophy (DMD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02354352Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy